UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 153

Sortiert nach

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

Scientific reports, 2020-11, Vol.10 (1), p.18802-18802, Article 18802

2020

Link zum Volltext

Verfügbarkeit prüfen

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

PloS one, 2011-02, Vol.6 (2), p.e16915-e16915

2011

Link zum Volltext

Verfügbarkeit prüfen

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

PloS one, 2023-01, Vol.18 (1), p.e0280507

2023

Link zum Volltext

Verfügbarkeit prüfen

Allele-specific copy number analysis of tumors

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (39), p.16910-16915

2010

Link zum Volltext

Verfügbarkeit prüfen

TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

Clinical cancer research, 2014-07, Vol.20 (13), p.3569-3580

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeted exploration and analysis of large cross-platform human transcriptomic compendia

Nature methods, 2015-03, Vol.12 (3), p.211

2015

Link zum Volltext

Verfügbarkeit prüfen

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

Nature communications, 2017-10, Vol.8 (1), p.1221-14, Article 1221

2017

Link zum Volltext

Verfügbarkeit prüfen

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers

Nucleic acids research, 2022-11, Vol.50 (21), p.12131

2022

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

Scientific reports, 2021-05, Vol.11 (1), p.10893-10893, Article 10893

2021

Link zum Volltext

Verfügbarkeit prüfen

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

Cell reports (Cambridge), 2019-12, Vol.29 (13), p.4389-4406.e10

2019

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic pan‐cancer analysis using rank‐based Bayesian inference

Molecular oncology, 2023-04, Vol.17 (4), p.548-563

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (8), p.2802-2807

2012

Link zum Volltext

Verfügbarkeit prüfen

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

Molecular oncology, 2019-10, Vol.13 (10), p.2278-2296

2019

Link zum Volltext

Verfügbarkeit prüfen

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer

PLoS computational biology, 2021-02, Vol.17 (2), p.e1008608-e1008608

2021

Link zum Volltext

Verfügbarkeit prüfen

ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines

Genes, 2023-01, Vol.14 (2), p.296

2023

Link zum Volltext

Verfügbarkeit prüfen

Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management

Breast (Edinburgh), 2016-08, Vol.28, p.136-144

2016

Link zum Volltext

Verfügbarkeit prüfen

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients

Cancers, 2023-09, Vol.15 (18), p.4662

2023

Link zum Volltext

Verfügbarkeit prüfen

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma

Scientific reports, 2017-07, Vol.7 (1), p.5568-15, Article 5568

2017

Link zum Volltext

Verfügbarkeit prüfen

Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4

Molecular oncology, 2018-09, Vol.12 (9), p.1540-1558

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer

Cancers, 2022-03, Vol.14 (5), p.1326

2022

Link zum Volltext

Verfügbarkeit prüfen

The Antigenicity of the Tumor Cell — Context Matters

The New England journal of medicine, 2017-02, Vol.376 (5), p.491-493

2017

Link zum Volltext

Verfügbarkeit prüfen

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

Frontiers in oncology, 2022-12, Vol.12, p.1016958-1016958

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data

PloS one, 2013-01, Vol.8 (1), p.e53014-e53014

2013

Link zum Volltext

Verfügbarkeit prüfen

Tumour hypoxia causes DNA hypermethylation by reducing TET activity

Nature (London), 2016-09, Vol.537 (7618), p.63-68

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 153

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink Journals - AutoHoldings

ThemaGenetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(151)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Humans
(79)
Life Sciences & Biomedicine
(76)
Breast Cancer
(59)
Female
(59)
Breast Neoplasms - Genetics
(46)
Oncology
(42)
Tumors
(40)
Gene Expression
(33)
Breast Neoplasms - Pathology
(21)
Cancer
(20)
Gene Expression Regulation, Neoplastic
(19)
Middle Aged
(18)
Dna Methylation
(17)
Multidisciplinary Sciences
(17)
Science & Technology - Other Topics
(17)
Mutation
(16)
Biological And Medical Sciences
(15)
Adult
(14)
Genomes
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

Allele-specific copy number analysis of tumors

TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

Targeted exploration and analysis of large cross-platform human transcriptomic compendia

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

Transcriptomic pan‐cancer analysis using rank‐based Bayesian inference

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer

ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines

Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma

Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4

Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer

The Antigenicity of the Tumor Cell — Context Matters

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data

Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers

Tumour hypoxia causes DNA hypermethylation by reducing TET activity

Aktive Filter

Suchergebnisse filtern